ATE528290T1 - Spiroindolinon-derivate - Google Patents

Spiroindolinon-derivate

Info

Publication number
ATE528290T1
ATE528290T1 AT09722134T AT09722134T ATE528290T1 AT E528290 T1 ATE528290 T1 AT E528290T1 AT 09722134 T AT09722134 T AT 09722134T AT 09722134 T AT09722134 T AT 09722134T AT E528290 T1 ATE528290 T1 AT E528290T1
Authority
AT
Austria
Prior art keywords
spiroindolinone derivatives
spiroindolinone
derivatives
compounds
general formulas
Prior art date
Application number
AT09722134T
Other languages
English (en)
Inventor
Jin-Jun Liu
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE528290T1 publication Critical patent/ATE528290T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/96Spiro-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
AT09722134T 2008-03-19 2009-03-09 Spiroindolinon-derivate ATE528290T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3779908P 2008-03-19 2008-03-19
PCT/EP2009/052737 WO2009115425A1 (en) 2008-03-19 2009-03-09 Spiroindolinone derivatives

Publications (1)

Publication Number Publication Date
ATE528290T1 true ATE528290T1 (de) 2011-10-15

Family

ID=40595697

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09722134T ATE528290T1 (de) 2008-03-19 2009-03-09 Spiroindolinon-derivate

Country Status (13)

Country Link
US (1) US7723372B2 (de)
EP (1) EP2265583B1 (de)
JP (1) JP2011515353A (de)
KR (1) KR20100121521A (de)
CN (1) CN101977898A (de)
AT (1) ATE528290T1 (de)
AU (1) AU2009226866A1 (de)
BR (1) BRPI0909333A2 (de)
CA (1) CA2716979A1 (de)
ES (1) ES2373857T3 (de)
IL (1) IL208025A0 (de)
MX (1) MX2010009927A (de)
WO (1) WO2009115425A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010319595B2 (en) * 2009-11-12 2015-09-17 The Regents Of The University Of Michigan Spiro-oxindole MDM2 antagonists
JP2014500870A (ja) 2010-11-12 2014-01-16 ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン スピロ−オキシインドールmdm2アンタゴニスト
CA2829188C (en) 2011-03-10 2016-10-18 Daiichi Sankyo Company, Limited Dispiropyrrolidine derivatives
CN102180828A (zh) * 2011-03-31 2011-09-14 四川大学 手性吲哚啉酮螺五环骨架化合物及不对称合成
ES2624808T3 (es) 2011-05-11 2017-07-17 The Regents Of The University Of Michigan Antagonistas de MDM2 espirooxindólicos
TWI586668B (zh) 2012-09-06 2017-06-11 第一三共股份有限公司 二螺吡咯啶衍生物之結晶
CN103172555B (zh) * 2012-12-07 2014-07-09 山东绿叶制药有限公司 升麻中分离的吲哚生物碱化合物、制备方法及其用途
JP2019522633A (ja) 2016-05-20 2019-08-15 ジェネンテック, インコーポレイテッド Protac抗体コンジュゲート及び使用方法
EP3511334A1 (de) * 2018-01-16 2019-07-17 Adamed sp. z o.o. 1,2,3',5'-tetrahydro-2'h-spiro[indol-3,1'-pyrrolo[3,4-c]pyrrol] -2,3'-dion-verbindungen als therapeutische mittel, die tp53 aktivieren
WO2023056069A1 (en) 2021-09-30 2023-04-06 Angiex, Inc. Degrader-antibody conjugates and methods of using same
WO2024240858A1 (en) 2023-05-23 2024-11-28 Valerio Therapeutics Protac molecules directed against dna damage repair system and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114937A (en) * 1989-11-28 1992-05-19 Warner-Lambert Company Renin inhibiting nonpeptides
FR2740136B1 (fr) 1995-10-24 1998-01-09 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
GB9819860D0 (en) * 1998-09-12 1998-11-04 Zeneca Ltd Chemical compounds
CA2752738C (en) * 2005-02-22 2014-05-27 The Regents Of The University Of Michigan Small molecule inhibitors of mdm2 and uses thereof
US7495007B2 (en) * 2006-03-13 2009-02-24 Hoffmann-La Roche Inc. Spiroindolinone derivatives
US20070213341A1 (en) * 2006-03-13 2007-09-13 Li Chen Spiroindolinone derivatives
US7638548B2 (en) 2006-11-09 2009-12-29 Hoffmann-La Roche Inc. Spiroindolinone derivatives
US20080188506A1 (en) 2007-02-07 2008-08-07 Qingjie Ding Spiroindolinone derivatives
US7553833B2 (en) * 2007-05-17 2009-06-30 Hoffmann-La Roche Inc. 3,3-spiroindolinone derivatives
US7834179B2 (en) 2007-05-23 2010-11-16 Hoffmann-La Roche Inc. Spiroindolinone derivatives

Also Published As

Publication number Publication date
CA2716979A1 (en) 2009-09-24
US7723372B2 (en) 2010-05-25
CN101977898A (zh) 2011-02-16
WO2009115425A1 (en) 2009-09-24
ES2373857T3 (es) 2012-02-09
IL208025A0 (en) 2010-12-30
EP2265583B1 (de) 2011-10-12
BRPI0909333A2 (pt) 2019-09-24
JP2011515353A (ja) 2011-05-19
AU2009226866A1 (en) 2009-09-24
EP2265583A1 (de) 2010-12-29
KR20100121521A (ko) 2010-11-17
MX2010009927A (es) 2010-09-30
US20090239889A1 (en) 2009-09-24

Similar Documents

Publication Publication Date Title
ATE528290T1 (de) Spiroindolinon-derivate
MX2009004766A (es) Derivados de espiroindolinona.
MX2009012345A (es) Derivados de 3,3-espiroindolinona.
BRPI0717266A2 (pt) Derivados de oxindol
ATE495176T1 (de) Spiroindolinon-derivate
CR20110099A (es) Pirrolidina-2-carboxamidas sustituidas
NO20083630L (no) Nye pyridinderivater
ECSP10010334A (es) Derivados de quinolina y su uso como fungicidas
PH12012501546A1 (en) Substituted pyrrolidine-2-carboxamides
BRPI0821255A2 (pt) Derivados de espiroindolinona
ATE524470T1 (de) Spiroindolinonderivate als antikrebsmittel
UY30881A1 (es) Derivados de fenotiazina, procedimientos y su uso como productos farmacéuticos
ECSP10010722A (es) Compuestos orgánicos
MY169043A (en) New dihydroquinoline-2-one derivatives
DK2134691T3 (da) Quinolinonderivativer som parp- og tank-inhibitorer
IN2012DN02487A (de)
UA107671C2 (en) N1-substityted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives
MX2012008141A (es) Compuestos y metodos.
MX2014014832A (es) Pirrolopirimidona y pirrolopiridona, inhibidores de tanquirasa.
ATE483000T1 (de) Naphtalin-amidin-imide
CR20110381A (es) Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2
TR201908180T4 (tr) N1-asil- 5-floropirimidinon deriveleri.
MX2012005155A (es) Compuestos de quinazolina.
ATE469647T1 (de) Thienoä3,2-cüpyridin-7-carbonsäure-derivate
UY28917A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties